Valacyclovir: Clinical Trials

124 trials of Valacyclovir, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

87 completed, 12 recruiting, 8 terminated, 7 unknown. 39 Phase 2, 30 Phase 1, 19 Not applicable, 19 Phase 4, 17 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 239Completed 25, Recruiting 6, Terminated 3, Active not recruiting 2, Unknown 2, Enrolling by invitation 1
Phase 130Completed 22, Unknown 3, Recruiting 2, Active not recruiting 1, Terminated 1, Withdrawn 1
Not applicable19Completed 14, Recruiting 2, Withdrawn 2, Terminated 1
Phase 419Completed 13, Terminated 2, Not yet recruiting 1, Recruiting 1, Unknown 1, Withdrawn 1
Phase 317Completed 12, Recruiting 2, Active not recruiting 1, Terminated 1, Unknown 1

Follow Valacyclovir: new trials by email Literature Review of Valacyclovir trials Research Report on Valacyclovir

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Aciclovir Versus Placebo for HSV-2 Meningitis
Acyclovir 50 MG/ML, Placebo - Herpes Simplex 2, Meningitis, Viral
Phase 4Not yet recruitingJacob Bodilsen1502027-01-012026-10-28
SARS-CoV-2 and Herpesvirus Inhibition for Ending Long COVID Dysfunction
Valacyclovir, Celecoxib, Paxlovid - Post-acute Sequelae of COVID-19, Long COVID
Phase 2RecruitingIcahn School of Medicine at Mount Sinai1502026-10-202026-10-28
Aglatimagene Besadenovec + Prodrug and Pembrolizumab vs Docetaxel for Stage IV Non-Squamous NSCLC Progressing on Pembrolizumab (AURORA)
Aglatimagene Besadenovec, Valacyclovir, Pembrolizumab - Non-squamous, Non-Small Cell Lung Cancer
Phase 3RecruitingCandel Therapeutics, Inc.5002026-06-152026-06-22
Virus-Based Gene Therapy (AdV-HSV1-TK and AdV-Flt3L) in Combination With Valacyclovir for the Treatment of Pediatric and Young Adult Patients With Resectable, Recurrent Primary Malignant Brain Tumors
Ad-hCMV-Flt3L, Ad-hCMV-TK, Biospecimen Collection - Recurrent Diffuse Hemispheric Glioma, H3 G34-Mutant, Recurrent Malignant Brain Neoplasm
Phase 1RecruitingUniversity of Michigan Rogel Cancer Center112026-05-222026-06-15
Study of an AAV Mediated Dual-Payload Gene Therapy in Patients With High Grade Glioma
TGX-007, Valaciclovir - Glioblastoma (GBM), High Grade Gliomas
Phase 1 / Phase 2RecruitingTrogenix ltd682026-04-212026-10-23
Is Valacyclovir Non-inferior to Valganciclovir as CMV and EBV Prophylaxis in Kidney Transplant Recipients? A Single-Center Prospective Randomized Pilot Study
Valacyclovir (Valtrex), Valganciclovir (Valcyte) - Kidney Transplantation, Cytomegalovirus Infections, EBV Infection
Not applicableRecruitingNational Taiwan University Hospital802025-11-272025-12-19
A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec
aglatimagene besadenovec + valacyclovir, External Beam Radiation Therapy (EBRT) - Prostate Cancer Patients Treated by Radiotherapy, Prostate Cancer (Adenocarcinoma)
Phase 2RecruitingCandel Therapeutics, Inc.452025-10-302026-09-15
Efficacy of Electroacupuncture for Acute Herpes Zoster-Associated Pain and Biomarker Evaluation
Acupuncture, Sham, Valacyclovir, pregabalin and mecobalamin - Acute Herpes Zoster
Not applicableRecruitingDexiong Han2282025-09-012026-06-16
Effect of Valaciclovir on Inter-Appointment Pain in Endodontic Treatment of Necrotic Teeth
Valacyclovir, Placebo - Symptomatic Apical Periodontitis
Not applicableCompletedTehran University of Medical Sciences382024-11-012025-06-11
Valacyclovir Monotherapy in Pain Management of Acute Periapical Abscesses After Emergency Chamber Opening
Valacyclovir 500 mg, Naproxen Sodium 550mg - Acute Apical Abscess
Phase 4UnknownDow University of Health Sciences822024-03-272024-04-10
Valacyclovir in Pain Management of Acute Apical Abscesses
Valacyclovir 500 MG, Placebo - Acute Apical Abscess, Pain, Acute
Phase 2RecruitingUniversity of California, San Francisco602023-10-252025-05-30
Prenatal Treatment of Congenital Cytomegalovirus Infection With Letermovir Versus Valaciclovir
Letermovir, Valacyclovir - Pregnant Women, CMV Infected Fetuses
Phase 3RecruitingAssistance Publique - Hôpitaux de Paris462023-10-202026-03-31
A Study of the Safety, Tolerability and Prelinminary Efficacy of BD111 in Herpes Simplex Virus Type I Stromal Keratitis
BD111 Injection (Investigative New Drug), Triple-drugs therapy of HSV-1 stromal keratitis - Herpes Simplex Virus Type I Stromal Keratitis
Phase 1Active not recruitingShanghai BDgene Co., Ltd.162023-09-042025-05-18
Neonatal Phase 1 Valacyclovir Study
Valacyclovir - Herpes Simplex
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)172023-08-072026-07-23
VZV in the Enteric Nervous System: Pathogenesis and Consequences
ValACYclovir 1000 MG, Shingrix - Achalasia
Phase 4RecruitingVanderbilt University Medical Center402023-03-272026-10-05
Ultrasound-Guided Thoracic Paravertebral Block With Steroid and Local Anesthetic for Acute Herpes Zoster: Effects on Pain Control and Prevention of Postherpetic Neuralgia
Valacyclovir + Paracetamol (Acetaminophen) + Gabapentin (standard medical therapy), Ultrasound-guided thoracic paravertebral block (TPVB) with bupivacaine 0.25% + methylprednisolone 40 mg - Postherpetic Neuralgia
Phase 3CompletedAssiut University1002023-03-152026-01-20
Time-limited Triplet Combination of Pirtobrutinib, Venetoclax, and Obinutuzumab for Patients With Treatment-naïve Chronic Lymphocytic Leukemia (CLL) or Richter Transformation (RT)
Pirtobrutinib, Obinutuzumab, Venetoclax - Leukemia
Phase 2RecruitingM.D. Anderson Cancer Center602022-12-202026-04-30
A Study Exploring Efficacy of Peginterferon in Patients With Herpes Zoster
Peginterferon α1b, Peginterferon α1b with valacyclovir, Valacyclovir - Herpes Zoster
Phase 2CompletedShanghai Institute Of Biological Products502022-10-112023-12-29
Oral Herpesviruses and Oral Mucositis in Patients Receiving Head and Neck Radiotherapy
Valacyclovir, Placebo - Oral Mucositis, Head and Neck Cancer (H&N)
Phase 2Enrolling by invitationInstituto Oncoclinicas842022-09-052026-01-23
Using Oral Valacyclovir to Treat Patients With Refractory IC/BPS
Valacyclovir - Pain, Chronic, Urge Incontinence
Phase 1UnknownBuddhist Tzu Chi General Hospital302021-07-012021-10-26

Showing 20 of 124. Sign in to see all of them.

Conditions studied

Herpes Simplex (25)  ·  Herpes Genitalis (21)  ·  HIV Infections (17)  ·  Herpes Zoster (15)  ·  Acquired Immunodeficiency Syndrome (6)  ·  Cytomegalovirus Infections (6)  ·  Glioblastoma (5)  ·  Neuralgia, Postherpetic (5)  ·  Chickenpox (4)  ·  Glioma (4)  ·  Prostatic Neoplasms (4)  ·  Recurrence (4)  ·  Sexually Transmitted Diseases (4)  ·  AIDS-Related Complex (3)  ·  Anus Diseases (3)

Sponsors

Candel Therapeutics, Inc. (11)  ·  University of Washington (9)  ·  GlaxoSmithKline (8)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (5)  ·  Glaxo Wellcome (4)  ·  Astellas Pharma Inc (3)  ·  M.D. Anderson Cancer Center (3)  ·  Mylan Pharmaceuticals Inc (3)  ·  Radboud University Medical Center (3)  ·  Assistance Publique - Hôpitaux de Paris (2)  ·  Baylor College of Medicine (2)  ·  Dr. Reddy's Laboratories Limited (2)  ·  Fred Hutchinson Cancer Center (2)  ·  NYU Langone Health (2)  ·  Ranbaxy Laboratories Limited (2)

Countries

United States (73)  ·  Canada (12)  ·  United Kingdom (7)  ·  China (4)  ·  India (4)  ·  Netherlands (4)  ·  Australia (3)  ·  Brazil (3)  ·  France (3)  ·  Germany (3)  ·  Sweden (3)  ·  Argentina (2)  ·  Chile (2)  ·  Japan (2)  ·  Kenya (2)

Top investigators

Anna Wald, MD, MPH (3)  ·  Connie Celum, MD, MPH (3)  ·  Dorian Williams, M.D. (3)  ·  Alan Copa, PharmD (2)  ·  Christine Johnston, MD, MPH (2)  ·  Darrell HS Tan, MD FRCPC (2)  ·  Davangere Devanand, MD (2)  ·  Dr. Dharmesh Domadia, MD (2)  ·  E. Antonio Chiocca, MD, PhD (2)  ·  Mary J Burton, MD (2)  ·  Sharon L Walmsley, MD FRCPC MSc (2)  ·  Susan Blaney, MD (2)

Results publications

PMID 22225814, PMID 16044019, PMID 17314338, PMID 17617198, PMID 18008230, PMID 18039954, PMID 18368417, PMID 18593294, PMID 18596069, PMID 18849193, PMID 18928378, PMID 19169140, PMID 19192993, PMID 19469706, PMID 21482862, PMID 21844505, PMID 21998479, PMID 22147786, PMID 22446565, PMID 22509337, PMID 22652942, PMID 22711350, PMID 22852760, PMID 23946220, PMID 24504006, PMID 24664172, PMID 25795132, PMID 25956891, PMID 26312852, PMID 26843484, PMID 27162003, PMID 27450392, PMID 27943311, PMID 27997653, PMID 28437539, PMID 28800385, PMID 29550074, PMID 30102389, PMID 30883662, PMID 32034019, PMID 32919517, PMID 33160076, PMID 35090154, PMID 37011709, PMID 38411973, PMID 38540138, PMID 39133650, PMID 40048183, PMID 40048191, PMID 40120123

NIH funding

2009 (1), 2016 (1), N01AI30025 (1), P01AI030731 (1), R01AG055422 (1), R03HD057773 (1), U10EY026869 (1), U54AI150225 (1), UM1CA137443 (1)